1,812 research outputs found
Supplemental Material, sj-docx-1-ptd-10.1177_08968608231214143 - Predicting transfer to haemodialysis using the peritoneal dialysis surprise question
No full textSupplemental Material, sj-docx-1-ptd-10.1177_08968608231214143 for Predicting transfer to haemodialysis using the peritoneal dialysis surprise question by Ayesha Anwaar, Sai Liu, Maria Montez-Rath, Hatsumi Neilsen, Sumi Sun, Graham Abra, Brigitte Schiller and Wael F Hussein in Peritoneal Dialysis International</p
Maria Rath ex librise
No full texthttp://www.lib.unideb.huDebreceni Egyetem Egyetemi és Nemzeti KönyvtárRomanizáló betűtípussal írt felirat fekete alapon, piros kezdőbetűvel: Ex libris Maria Rath. Balra kalligrafikus díszítés, alul Dávid-csillaggal, ebben a Szentlélek galambja. A szerző/tulajdonos neve az ex libris hátlapjára felvezetve.metsze
Kunstsammlung und Hauseinrichtung Frau Maria vom Rathgeb. Stein +, Köln, Domstrasse 19 : Gold, Goldemail, Halbedelsteine, alte Silberschmiedearbeiten, Bildnisminiaturen, Dosen, Fächer, Gemälde, Plastiken in Holz, Buchsbaum, Elfenbein, Marmor, Alabaster, europäisches und ostasiatisches Porzellan, Fayence, Glas, Bronze und Messing, Mobiliar, Stickereien, Aubussons, Orientteppiche ; [Besichtigung im Hause Köln, Domstrasse 9 ..., Versteigerung ebendaselbst 25.-26. März 1936] /
No full textNiet geannoteerdAuktionskatalog. - NT: Sammlung Frau Maria vom Rath geb. Stein, + 1924, Köln, Domstrasse 19
Chants d'Espagne / Manolo Montez, chant ; accompagné par F. Betoret, p
No full textComprend : Te le juro yo - Los chumbeles - Copla sevillana - Maria DoloresBnF-Partenariats, Collection sonore - BelieveContient une table des matière
"Lolaland " by Lola Montez, Comtesse de Landsfelt and Lindsay Wilson
No full textIs an accurate representation of self possible in biographical theatre? Lola Montez (1821-1861) was a historical figure known for being the worst actress and dancer of her generation. However, Montez stated, after her rise to political infamy in Bavaria, that "she no longer recognize[d] herself as Lola Montez." In an act of reinvention, after being chased out of Bavaria, she expressed the desire to create "Lolaland" an independent state with her as leader--an outrageous goal which she never achieved. "Lolaland" transposes Plato's "Theory of Forms" utilizing the idea that there are two distinct levels of reality: the world of sights and sounds which we inhabit and the intelligible world of forms that stands above the visible world and gives it being. This, in turn, reflects a modern preoccupation with fame and celebrity. Celebrity reflects a type of mythology that encourages people to aspire to a different class through a constant performance or mimicry of what they believe makes someone celebrated. The coterie of Montez followers that populate this play fight for their place, and vie to ascend their position in the Republic, in order to become celebrated including the author who places herself as an imagined self in the imagined myth of Lola Montez. "Keen and unremitting in his love, he will go on till he touches the nature of each thing which is by itself with that part of his soul which is suited to grasp it. But it is suited to what it is akin. Drawing near it and having intercourse with what is really real, begetting thought and truth, he knows and truly lives and is nourished, and thus, but not before, ceases from his travail." -- Plato, "The Republic" "Tyranny is not a matter of minor theft and violence, but of wholesale plunder, sacred and profane, private or public." -- Plato, "The Republic
Frohe Wünsche bey der Vermählungsfeyer Ihro Herzoglichen Durchlaucht Herrn Carl Friedrich Erbprinzen zu Sachsen Weimar und Eisenach mit Ihro Kaiserlichen Hoheit Maria Pawlowna Grossfürstin von Russland in Unterthänigkeit dargebracht von dem Rath und der Bürgerschaft der Stadt Lobeda. Im November 1804
No full textFROHE WÜNSCHE BEY DER VERMÄHLUNGSFEYER IHRO HERZOGLICHEN DURCHLAUCHT HERRN CARL FRIEDRICH ERBPRINZEN ZU SACHSEN WEIMAR UND EISENACH MIT IHRO KAISERLICHEN HOHEIT MARIA PAWLOWNA GROSSFÜRSTIN VON RUSSLAND IN UNTERTHÄNIGKEIT DARGEBRACHT VON DEM RATH UND DER BÜRGERSCHAFT DER STADT LOBEDA. IM NOVEMBER 1804
Frohe Wünsche bey der Vermählungsfeyer Ihro Herzoglichen Durchlaucht Herrn Carl Friedrich Erbprinzen zu Sachsen Weimar und Eisenach mit Ihro Kaiserlichen Hoheit Maria Pawlowna Grossfürstin von Russland in Unterthänigkeit dargebracht von dem Rath und der Bürgerschaft der Stadt Lobeda. Im November 1804 ( - )
Cover ( - )
Titelseite ([1])
Text ([2]
Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study
No full textBackground: Impaired kidney function is an established predictor of mortality after acute nonvariceal upper gastrointestinal bleeding (ANVUGIB); however, which factors are associated with mortality after ANVUGIB among patients undergoing dialysis is unknown. We examined the associations among demographic characteristics, dialysis-specific features, and comorbid conditions with short-term mortality after ANVUGIB among patients on dialysis.
Methods: Design: Retrospective cohort study. Setting: United States Renal Data System (USRDS), a nation-wide registry of patients with end-stage renal disease. Participants: All ANVUGIB episodes identified by validated algorithms in Medicare-covered patients between 2003 and 2007. Measurements: Demographic characteristics and comorbid conditions from 1 year of billing claims prior to each bleeding event. We used logistic regression extended with generalized estimating equations methods to model the associations among risk factors and 30-day mortality following ANVUGIB events.
Results: From 2003 to 2007, we identified 40,016 eligible patients with 50,497 episodes of ANVUGIB. Overall 30-day mortality was 10.7% (95% CI: 10.4-11.0). Older age, white race, longer dialysis vintage, peritoneal dialysis (vs. hemodialysis), and hospitalized (vs. outpatient) episodes were independently associated with a higher risk of 30-day mortality. Most but not all comorbid conditions were associated with death after ANVUGIB. The joint ability of all factors captured to discriminate mortality was modest (c=0.68).
Conclusions: We identified a profile of risk factors for 30-day mortality after ANVUGIB among patients on dialysis that was distinct from what had been reported in non-dialysis populations. Specifically, peritoneal dialysis and more years since initiation of dialysis were independently associated with short-term death after ANVUGIB
Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005)
No full textBackground: Little is known about the incidence of intestinal perforation in patients undergoing dialysis. Concerns exist that sevelamer hydrochloride may increase the risk of intestinal perforation. We examined long-term trends for the incidence of intestinal perforation among US dialysis patients.
Methods: We studied all dialysis patients (1992-2005) who had Medicare as primary payer. We used ICD-9 diagnosis code 569.83 to ascertain events of intestinal perforation. We studied (a) all perforations and (b) perforations that did not appear to be associated with specific causative conditions (specific diseases or iatrogenic procedures within 7 days of perforation). We used Poisson regression to model the annual number of intestinal perforations and tested for any changes in levels and temporal trends of incidence rates before versus after January 1, 1999.
Results: Overall, 1,060,132 patients contributed 2.7 million patient-years. We observed 12,355 events of intestinal perforation and 7,814 spontaneous perforations. The corresponding, incidence rates were 4.6 (total) and 2.9 (spontaneous perforation) episodes per 1,000 person-years, respectively. For both outcome definitions, 30-day mortality was 42%. Unadjusted and adjusted incidence rates were not materially different over time. Formal tests for any changes in the level or slope of incidence comparing time periods before and after January 1, 1999, indicated no evidence for any changes in the incidence of intestinal perforation over time.
Conclusions: In US dialysis patients, incidence of intestinal perforation was low, but associated with high short-term mortality. We did not detect any significant changes in the incidence of intestinal perforation before versus after approval of sevelamer hydrochloride in late 1998
Eat Move Sleep : How Small Choices Lead to Big Changes
No full text#1 "New York Times" bestselling author Tom Rath delivers a book that will improve your health for years to come in three of interconnected areas: eating, moving, and sleeping.Quietly managing a serious illness for more than 20 years, Rath has assembled a wide range of information on the impact of eating, moving, and sleeping. He offers advice that will help you make good decisions automatically, in all three of these interconnected areas. With every bite you take, you will make better choices. You will move a lot more than you do today. And you will sleep better than you have in years.x+227p.;14x21c
Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients
No full textImpaired kidney function is a risk factor for upper gastrointestinal (GI) bleeding, an event associated with poor outcomes. The burden of upper GI bleeding and its effect on patients with ESRD are not well described. Using data from the US Renal Data System, we quantified the rates of occurrence of and associated 30-day mortality from acute, nonvariceal upper GI bleeding in patients undergoing dialysis; we used medical claims and previously validated algorithms where available. Overall, 948,345 patients contributed 2,296,323 patient-years for study. The occurrence rates for upper GI bleeding were 57 and 328 episodes per 1000 person-years according to stringent and lenient definitions of acute, nonvariceal upper GI bleeding, respectively. Unadjusted occurrence rates remained flat (stringent) or increased (lenient) from 1997 to 2008; after adjustment for sociodemographic characteristics and comorbid conditions, however, we found a significant decline for both definitions (linear approximation, 2.7% and 1.5% per year, respectively; P<0.001). In more recent years, patients had higher hematocrit levels before upper GI bleeding episodes and were more likely to receive blood transfusions during an episode. Overall 30-day mortality was 11.8%, which declined significantly over time (relative declines of 2.3% or 2.8% per year for the stringent and lenient definitions, respectively). In summary, despite declining trends worldwide, crude rates of acute, nonvariceal upper GI bleeding among patients undergoing dialysis have not decreased in the past 10 years. Although 30-day mortality related to upper GI bleeding declined, perhaps reflecting improvements in medical care, the burden on the ESRD population remains substantial
- …
